Blog

Tokyo, Japan, Apr 1: Marking its 60th anniversary, transcosmos  announced its Purpose to remain an indispensable company to society and achieve sustainable growth. Along with the Purpose, transcosmos has defined its Vision for the next 10 years and the Values that guide each employee’s daily decision-making and actions, establishing a renewed philosophy structure. As its business continues to grow and its domains and social relationships expand, this structure clarifies the company’s essential drivers of growth and fosters unity among employees by sharing the common values across the organization. Through this, transcosmos aims to create even greater social value and remain the company of choice for all stakeholders. Inheriting the spirit of “people & technology” that sits at the heart of its business from its founding, transcosmos will take a step forward toward the next growth phase with a renewed Purpose, Vision, and Values at its core.

Purpose

Make It Real, Together. By transcending limits and connecting people through technology, we open a universe of possibilities for growth and success. Amid rapidly changing societal and business environments, companies today are expected not only to demonstrate efficiency and technological strength but also to show how—and with whom—they create value. transcosmos has long brought wishes and passion of clients and society to life by treating their challenges as its own, discussing and addressing their problems together from planning to execution, and delivering tangible results together. By upholding this Purpose, transcosmos seeks to extend its ability to Make It Real to a wider global audience by multiplying autonomous capabilities of each individual.

Vision

Powering Intelligent Businesses through Consulting, Technology, and Operations transcosmos defined the above as its medium-term vision. Today, advanced companies are aiming to transform into an Intelligent Business, a next-generation business with advanced, autonomous decision-making and execution capabilities with AI and data at their core. Recognizing this trend, transcosmos aims to serve as a powerful engine that helps propel clients’ transformation by enhancing its consulting and technological capabilities.

Values

To achieve its Purpose and Vision, transcosmos has defined values that guide each employee’s daily decision-making and actions.

– Deliver results as one team. – Build trust through integrity and sincerity. – Take ownership and think beyond. – Grow through every challenge. – Create a fair environment for everyone.

[Next steps] Under the Purpose, Vision, and Values, transcosmos will strive to deliver its medium-term business plan, which starts in fiscal year 2026, and the vision beyond, to further enhance its corporate value and create greater social value.

* transcosmos is a trademark or registered trademark of transcosmos inc. in Japan and other countries.
* Other company names and product or service names used here are trademarks or registered trademarks of respective companies.

Mumbai, April 1, 2026: Mahindra & Mahindra Ltd. (M&M Ltd.), today announced that its overall sales including exports in the Trucks and Buses business (CV > 3.5T) for the month of March 2026 stood at 4267 vehicles, a y-o-y growth of 13%.  

Mahindra’s Trucks & Buses business comprises of Mahindra Trucks & Buses division (MTBD) and SML Mahindra Limited (SML).

According to Vinod Sahay, Executive Chairman – SML, President – Aerospace, Defence, Trucks, Buses & CE, M&M, “Despite the headwinds faced from global geopolitical tensions and elevated crude prices, the commercial vehicle industry has sustained its strong momentum, underscoring the sector’s resilience. Looking ahead, the trajectory for F27 remains mixed – while replacement demand and government-led projects are expected to support volumes, volatility in fuel costs and supply chain constraints could temper sentiment.” 

Mumbai, Apr 1: In a major development, Lloyds Metals and Energy Limited (LMEL) has announced the successful acquisition of the CHEMAF Group comprising Chemaf Resources Limited, Chemaf SA, and associated entities  leading copper and cobalt mining and processing companies operating in the Democratic Republic of Congo (DRC). The acquisition was executed on March 27, 2026, through Virtus Lloyds Minerals Holding (VLMH), a joint venture between entity of Lloyds Metals (49%) and Virtus Minerals Inc., a US-headquartered mining investment company.

Located in the heart of the Katanga Copper Belt – one of the richest copper‑cobalt geological zones in the world—the CHEMAF assets significantly enhance Lloyds Metals’ footprint in critical minerals essential to the global energy transition. The DRC holds over 70% of the world’s cobalt reserves and is among the largest producers of copper globally.

Sooryanarayan Prabhakaran, the Managing Director of the Lloyds Operations in Congo, said

“This acquisition marks the first transaction executed under the U.S.–DRC Strategic Partnership Agreement, signed in Washington, D.C., on December 4, 2025. This landmark pact promotes cooperation in critical minerals—copper, cobalt, lithium, and tantalum—between the United States and the DRC, advancing secure, sustainable, and transparent global supply chains. “

Through VLMH, Lloyds Metals will operate and run the acquired mining and processing assets and manage the entire value chain from mine development to offtake. Upon completion of ongoing expansion projects, the production capacity in the DRC is projected to reach approximately 100,000 tonnes per annum (TPA) of copper and 20,000 TPA of cobalt, with peak revenues estimated at USD 1.5 billion  annually.

The acquisition underscores Lloyds Metals’ transformation from one of India’s major iron and steel companies into a global mining enterprise. It strategically positions the Group within international efforts to diversify critical mineral supply chains and support the accelerating clean‑energy and electric‑vehicle revolution

“This acquisition represents a definitive step in the evolution of Lloyds Metals as a globally integrated mining group,” said Mr. B. Prabhakaran, Managing Director, Lloyds Metals and Energy Limited. “By establishing a foothold in one of the world’s most resource‑rich regions, we are laying the foundations for long‑term value creation, technological collaboration, and sustainable growth across the copper and cobalt value chains. It is a step that reflects both our confidence in the future of critical minerals and our commitment to building resilient global partnerships that power the energy transition.”

With the completion of this acquisition, Lloyds Metals joins the ranks of international mining players contributing to a more resilient and diversified global minerals ecosystem.

Presented by actor, entrepreneur and wellness advocate, Shilpa Shetty Kundra, the Chief Guest, at the Udyog Yogdaan Puraskar 2026 in association with Karnataka Tourism

Apr 01: On March 28, 2026, Rashmi Aiyappa – Spiritual Scientist & Inventor of Aashwasan Science®, Founder & Executive Chairperson of Aashwasan Group of Companies, and Founder & Managing Trustee of Aashwasan Foundation – was conferred the Lifetime Achievement Award – Wellness Industry (India) by Shilpa Shetty Kundra at the Udyog Yogdaan Puraskar 2026.

The event, held in association with Karnataka Tourism, was graced by industry leaders, successful entrepreneurs, and accomplished social personalities. The Udyog Yogdaan Puraskar is a distinguished recognition that honours individuals whose exemplary contributions have created a lasting legacy in their respective fields.

Rashmi Aiyappa was honoured for her exceptional contributions to the Health & Wellness sector. Through her pioneering invention, Aashwasan Science®, she introduced a transformative approach that, for the first time, brings quantum science into lived human experience—enabling individuals to embrace their full potential and celebrate their infinite self.

Aashwasan Science® fosters holistic well-being at physiological, psychological, and spiritual levels, marking a significant breakthrough in how wellness is understood and experienced.

About Rashmi Aiyappa

• Spiritual Scientist, Inventor and Social Innovator
• Founder & Executive Chairperson – Aashwasan Group of Companies, Epiance Software, Aank Humane Technologies
• Founder & Managing Trustee – Aashwasan Foundation

A visionary and revolutionary entrepreneur, Rashmi Aiyappa was born with the experience of nature’s phenomena: Lifeforce Mechanism® and Timeless Phenomenon®, which encompass the knowledge of life’s mechanisms and the cause-and-effect cycle of nature.

Through these phenomena, she developed Aashwasan Science®—a groundbreaking spiritual technology rooted in quantum principles. This science bridges the physical and metaphysical realms, offering an experiential understanding of the multidimensional reality of the infinite self. It integrates the mechanisms of all life forms into a unified dynamic framework, addressing the root causes of challenges ranging from disease and life situations to relationships and self-awareness.

To bring this science to the world, Rashmi Aiyappa founded Aashwasan® on May 23, 2005. Over the past two decades, her work has led to 100+ breakthroughs in Health & Wellness, impacting millions of lives across 30+ countries. Her innovations have empowered individuals to discover their infinite identities and enabled organizations to undergo profound transformation.

She describes Aashwasan as a manifestation of her life’s purpose—a space where hope is restored and life is celebrated in its entirety.

In her words:
“Aashwasan is nature’s own. It’s a revolution that will continue for lifetimes and is here to stay. The only essence that marks life is love. Love is where it all begins.”

Media Presence

Between 2005 and 2012, Rashmi Aiyappa and her work were prominently featured across multiple media houses, news channels, radio platforms, and over 250 publications worldwide.

Awards and Recognitions

• 2013 – Social Innovator, CMO Asia Awards (Singapore)
• 2017 – Iconic Women Creating a Better World for All, Women Economic Forum
• 2017 – 50 Most Impactful Social Innovators, World CSR Congress
• 2018 – Global Peace Leadership & Excellence Award, World Peace Conference
• 2019–2021 – Mahatma Awards (Social Good, Impact Leadership, Maximising Human Potential)
• 2021–2022 – Among Top Women CEOs, Women Entrepreneur Magazine
• 2023 – Forbes Recognition as eXtrepreneur (Top 200 Companies with Global Potential)
• 2024 – Influential Leader in Mindfulness, Global Leaders Today Magazine
• 2025 – Best Brand 2025, Economic Times Conclave
• 2026 – Lifetime Achievement Award – Wellness Industry (India), Udyog Yogdaan Puraskar 2026 in association with Karnataka Tourism

Eleventh annual convening will unite patients, survivors, researchers, clinicians, industry leaders, and lawmakers to strengthen advocacy and advance public health protections

NEW YORK, NY | Apr 1 — The Peggy Lillis Foundation (PLF), the nation’s leading nonprofit dedicated to C. diff education and advocacy, today announced its 2026 National C. diff Summit and Lobby Day, taking place Monday, April 13, 2026, in our nation’s capitol. 

Since the organization’s founding, PLF has trained and supported C. diff survivors, caregivers, and family members to become effective advocates, public speakers, and peer supporters. Over the past decade, the Foundation has hosted ten National C. diff Summits and seven Lobby Days, building a national movement focused on care, community, and empowerment. 

The 2026 Summit will bring together C. diff survivors, caregivers, clinicians, researchers, industry partners, and policymakers for a full day of programming designed to elevate patient voices and accelerate solutions to this ongoing public health threat. 

“Sixteen years after the death of my mother, Peggy, there has been progress but also setbacks. C. diff continues to cause harm, and too many patients still struggle to access timely diagnosis, effective treatment, and informed care,” said Christian John Lillis, co-founder and CEO of the Peggy Lillis Foundation. “The Summit and Lobby Day bring together the people closest to this issue to push for solutions that improve outcomes and save lives. When lived experience, science, and policy come together, we accelerate progress.”

Monday morning will feature updates from leading experts in infectious disease research, clinical care, public health, and industry innovation, including: 

• Access to Microbiota Therapies for rCDI in 2026 – Michael Woodworth, MD, Assistant Professor of Medicine in the Division of Infectious Diseases, Emory University School of Medicine

• Diagnostic Stewardship of Testing for C. difficile – Jonathan Baghdadi, MD, PhD, Associate Professor of Medicine, University of Maryland School of Medicine and University of Maryland Medical Center

• Why Current C. diff Prevention Misses Half the Problem – Bobby Warren, MPS, Lab Director & Research Scientist, Duke University DiRTE Lab (Dissemination and Implementation Research in Translation and Effectiveness)

• Bringing the Threat of C. diff into Focus to Save Lives Now – Michael McIntyre, Founder and CEO, LIV Process

• Epidemiology of Pediatric C. diff – Jenna Simes, Clinical Research Coordinator, Boston Children’s Hospital

• Pediatric C. diff: Patient and Provider Panel – Stacy A. Kahn, MD, Director of the Fecal Microbiota Transplantation Program and Gastroenterologist in the Division of Gastroenterology, Hepatology and Nutrition at Boston Children’s Hospital. Dr. Kahn will also be joined by Rose Henderson and Blanca Morales, who will share their experience as parents of children who battled recurrent C. diff.

Following a networking lunch, attendees will participate in hands-on advocacy training designed to equip volunteers with practical tools to drive change at the local and national level. 

Training sessions will include:

• Lobbying and testifying before legislators and regulatory bodies

• Providing emotional and logistical support to C. diff patients and families

• Advocating to the Food and Drug Administration and other regulatory agencies

On Tuesday, April 14, advocates will convene on Capitol Hill for Lobby Day, meeting directly with members of Congress and their staff to urge continued investment in antimicrobial and microbiome drug development, antimicrobial resistance initiatives, and policies that reduce the burden of C. diff infections.

The National C. diff Summit and Lobby Day represent the largest annual gathering of C. diff patient advocates and allies across industry, academia, and government. The event serves as a platform for collaboration, education, and coordinated action to protect patients and prevent avoidable harm.

Registration for the Summit is free and open to C. diff patients, survivors, caregivers, healthcare professionals, researchers, policymakers, and all stakeholders committed to ending the harm caused by C. diff infections. To register or learn more, visit https://cdiff.org/event/summit26/. 

Lead Sponsor: Nestlé Health Science

Platinum Sponsor: Pfizer